HighTower Advisors
LABU icon

HighTower Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

HighTower Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-400
Closed -$3.52K – 3571
2023
Q1 		$3.52K Buy
+400
New +$54.2K ﹤0.01% 3256

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HighTower Advisors's LABU Position: Q1 2026 in Review

HighTower Advisors reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 60% in Q1 2026, selling an estimated $346K and leaving 1,400 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #3369.

HighTower Advisors first reported a position in LABU in Q2 2020 and has held it in 6 quarters since. The position peaked at $559K in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • HighTower Advisors held 1,400 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $233K as of Q1 2026.
  • HighTower Advisors sold 2,110 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $346K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3369 holding.
  • HighTower Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and has held it in 6 quarters since.
  • HighTower Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $559K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.